MeSH tree: N02.421.585.400
Achieving the Healthy People 2030 target of 70% immunization could substantially reduce the burden of influenza-related outpatient visits, hospitalizations, and deaths, while easing pressure on pediatric health care infrastructure ...
Apr 24, 2026
0
3
A federal report pointing out the benefits of COVID-19 vaccines may never be released, according to multiple people familiar with the decision.
Apr 22, 2026
4
6
A clinical trial led by UT Southwestern Medical Center researchers demonstrates that providing healthy food directly to patients recovering from heart failure is feasible and well accepted—and could improve quality of life—helping ...
Apr 12, 2026
0
7
As electric scooters (e-scooters) become more available in cities and urban areas, injuries are becoming more common—especially among teenage boys. This is among the findings from a new study using a national database of ...
Apr 7, 2026
0
2
Older hospitalized patients who struggled with taking their medications correctly were 10% less likely to need to return to the hospital if they had a pharmacist's help at discharge, according to a new multisite clinical ...
Apr 6, 2026
0
4
In nursing homes, influenza spreads quickly. Even in facilities with separate wings, staff move throughout the home, caring for medically complex older adults who often share rooms. In this way, a single case of influenza ...
Mar 31, 2026
0
3
Having a primary care physician reduces emergency department (ED) use among patients with end-stage kidney disease receiving dialysis, according to a study published in JAMA Network Open.
Mar 20, 2026
0
3
A new study led by University of Toronto researchers finds that post-surgical recovery time in older adults is much longer than expected, with data showing nearly 20% still have impairments in activities of daily living. ...
Mar 17, 2026
0
9
Adults over age 65 experience greater numbers of emergency hospitalizations for cardiovascular and respiratory diseases during and after power outages, reports a new study by Heather McBrien of Columbia Mailman School of ...
Mar 12, 2026
0
9
In a phase 3 clinical trial, the tetravalent dengue vaccine, developed by the Butantan Institute in São Paulo, Brazil, was 80.5% effective against severe dengue cases with warning signs over a five-year period. The results ...
Mar 11, 2026
0
11
